Merck starts recruitment for COVID-19 vaccine human trial

0
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo

(Reuters) – U.S. drugmaker Merck & Co Inc has begun recruiting participants to its early-stage COVID-19 vaccine study, according to the government database clinicaltrials.gov.

The study is based in Belgium and aims to recruit 260 participants. The WSJ first reported the news.

Earlier this month, Chief Executive Officer Kenneth Frazier had said the company aims to start human trials on one of its COVID-19 vaccine candidates “fairly soon,” with a second vaccine candidate likely to begin trials later this year.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Arun Koyyur)

Share

LEAVE A REPLY

Please enter your comment!
Please enter your name here


By submitting this form, you are consenting to receive marketing emails from: News India Times | Desi Talk Headlines | Desi Talk Chicago, 35 JOURNAL SQ, JERSEY CITY, NJ, 07306, http://www.newsindiatimes.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact